Home/NOVITÀ/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesNOVITÀTIF News (IT) TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Meno di un minuto 211020_ TIF Announcement_COVID-19 Vaccine Boosters TagPatients Healthcare Professionals AtRisk COVID-19 Vaccines Sickle cell Vulnerable #news TIF News COVID-19 Pandemic COVID-19 Vaccinations Haemoglobin Disorders Thalassaemia Meno di un minuto Facebook X LinkedIn Condividi via mail Stampa
